166 related articles for article (PubMed ID: 36449008)
81. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
82. Rapid and sensitive point-of-care detection of Leptospira by RPA-CRISPR/Cas12a targeting lipL32.
Jirawannaporn S; Limothai U; Tachaboon S; Dinhuzen J; Kiatamornrak P; Chaisuriyong W; Bhumitrakul J; Mayuramart O; Payungporn S; Srisawat N
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010112. PubMed ID: 34990457
[TBL] [Abstract][Full Text] [Related]
83. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Yu S; Kwon MJ; Lee EH; Park H; Woo HY
J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
[TBL] [Abstract][Full Text] [Related]
84. A microfluidic-chip-based system with loop-mediated isothermal amplification for rapid and parallel detection of
Mao Z; Deng A; Jin X; Li M; Lv W; Huang L; Zhong H; Yang H; Wang S; Shi Y; Zhang L; Liao Q; Huang G
Analyst; 2023 Sep; 148(19):4820-4828. PubMed ID: 37606537
[TBL] [Abstract][Full Text] [Related]
85. An enhanced method for nucleic acid detection with CRISPR-Cas12a using phosphorothioate modified primers and optimized gold-nanopaticle strip.
Gong J; Kan L; Zhang X; He Y; Pan J; Zhao L; Li Q; Liu M; Tian J; Lin S; Lu Z; Xue L; Wang C; Tang G
Bioact Mater; 2021 Dec; 6(12):4580-4590. PubMed ID: 34095617
[TBL] [Abstract][Full Text] [Related]
86. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
Wang X; Wu S; Li Y
J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
[TBL] [Abstract][Full Text] [Related]
87. Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.
Jendoubi-Ferchichi M; Satouri L; Ghoul F; Malek-Mellouli M; Derbel AM; Makni MK; Reziga H; Baba A; Zili M; Segondy M; Khelifa R
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3361-3366. PubMed ID: 30583341
[TBL] [Abstract][Full Text] [Related]
88. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
[TBL] [Abstract][Full Text] [Related]
89. Simultaneous detection of CaMV35S and T-nos utilizing CRISPR/Cas12a and Cas13a with multiplex-PCR (MPT-Cas12a/13a).
Cao G; Dong J; Chen X; Lu P; Xiong Y; Peng L; Li J; Huo D; Hou C
Chem Commun (Camb); 2022 May; 58(43):6328-6331. PubMed ID: 35527517
[TBL] [Abstract][Full Text] [Related]
90. [Performance of high-risk HPV typing test in early diagnosis of cervical cancer].
Wang P; Guo Z; Zhao DM; Xu HF; Jia MM; Ren LY; Chen PP; Sun XY; Li MJ; Sun XB; Qiao YL; Zhang SK
Zhonghua Yi Xue Za Zhi; 2020 May; 100(18):1396-1400. PubMed ID: 32392990
[No Abstract] [Full Text] [Related]
91. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
92. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W
Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
[TBL] [Abstract][Full Text] [Related]
93. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
[No Abstract] [Full Text] [Related]
94. Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.
Lamin H; Eklund C; Elfström KM; Carlsten-Thor A; Hortlund M; Elfgren K; Törnberg S; Dillner J
BMJ Open; 2017 May; 7(5):e014788. PubMed ID: 28566363
[TBL] [Abstract][Full Text] [Related]
95. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
[TBL] [Abstract][Full Text] [Related]
96. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
Isidean SD; Coutlée F; Franco EL
Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
[TBL] [Abstract][Full Text] [Related]
97. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
98. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
[TBL] [Abstract][Full Text] [Related]
99. Ultrasensitive and visual detection of human norovirus genotype GII.4 or GII.17 using CRISPR-Cas12a assay.
Qian W; Huang J; Wang T; Fan C; Kang J; Zhang Q; Li Y; Chen S
Virol J; 2022 Sep; 19(1):150. PubMed ID: 36115975
[TBL] [Abstract][Full Text] [Related]
100. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
